Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.92 HKD
Change Today +0.02 / 0.29%
Volume 13.4M
1093 On Other Exchanges
Hong Kong
As of 4:01 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

cspc pharmaceutical group lt (1093) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/17/15 - $8.57
52 Week Low
02/11/15 - $5.81
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CSPC PHARMACEUTICAL GROUP LT (1093)

Related News

No related news articles were found.

cspc pharmaceutical group lt (1093) Related Businessweek News

No Related Businessweek News Found

cspc pharmaceutical group lt (1093) Details

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug for the treatment of lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs; and products, such as benzylpenicillin sodium, ampicillin sodium, cefazolin sodium, cafradin, ceftriaxone, cefotaxime sodium, cefoperazone sodium, amoxicillin capsule, amoxicillin dispersible tablet, amoxicillin granule, etc. In addition, it has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infective. Further, the company is involved in the provision of pharmaceutical research and development services; sewage and pharmaceutical by-products treatment activities; and trading of pharmaceutical products. It has operations in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is based in Wan Chai, Hong Kong.

10,314 Employees
Last Reported Date: 08/25/15
Founded in 1997

cspc pharmaceutical group lt (1093) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: $4.4M
Executive Director
Total Annual Compensation: $2.0M
Executive Director
Total Annual Compensation: $798.0K
Executive Director
Total Annual Compensation: $798.0K
Executive Director
Total Annual Compensation: $798.0K
Compensation as of Fiscal Year 2014.

cspc pharmaceutical group lt (1093) Key Developments

CSPC Pharmaceutical Group Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

CSPC Pharmaceutical Group Limited reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported revenue of HKD 5,730,375,000 compared to HKD 5,342,470,000 a year ago. Operating profit was HKD 1,070,967,000 compared to HKD 801,446,000 a year ago. Profit before tax was HKD 1,047,419,000 compared to HKD 771,689,000 a year ago. Profit for the period was HKD 830,020,000 compared to HKD 609,426,000 a year ago. Profit for the period attributable to owners of the company was HKD 822,014,000 compared to HKD 600,665,000 a year ago. Diluted earnings per share were 13.76 cents compared to 10.07 cents a year ago.

CSPC Pharmaceutical Group Limited to Report First Half, 2015 Results on Aug 25, 2015

CSPC Pharmaceutical Group Limited announced that they will report first half, 2015 results on Aug 25, 2015

CSPC Pharmaceutical Group Limited, Board Meeting, Aug 25, 2015

CSPC Pharmaceutical Group Limited, Board Meeting, Aug 25, 2015. Agenda: To approve unaudited results of the company and its subsidiaries for the six months ended June 30, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1093:HK $6.92 HKD +0.02

1093 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1093.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1093 Industry Range
Price/Earnings 27.7x
Price/Sales 3.6x
Price/Book 4.9x
Price/Cash Flow 27.4x
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSPC PHARMACEUTICAL GROUP LT, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at